HIV positive (N = 147) | HIV negative (N = 151) | |||
---|---|---|---|---|
N (%)b | N(%) | P valuec | OR (95% CI)d | |
Age (years) | ||||
Mean ± SD | 40.6 ± 10.1 | 35.0 ± 19.1 | 0.0024* | 1.02 (1.01, 1.04) |
Female | 90 (61.2%) | 71 (47.0%) | 0.0142* | 1.78 (1.12, 2.82) |
Dar es Salaam residence | 60 (40.8%) | 46 (30.5%) | 0.0627 | 1.57 (0.98, 2.54) |
Advanced cancer stage (% of reported) | 43 (95.6%) | 48 (78.7%) | 0.0254* | 5.82 (1.24, 27.29) |
Cancer treatment | ||||
Radiotherapy | 110 (75.3%) | 68 (46.9%) | <.0001* | 3.5 (2.10, 5.70) |
Chemotherapy | 51 (35.2%) | 105 (72.4%) | <.0001* | 0.21 (0.13, 0.34) |
Both | 40 (27.6%) | 41 (28.3%) | 0.8959 | 0.97 (0.58, 1.61) |
Co-morbidities | ||||
Mean ± SD (count) | 0.61 ± 0.86 | 1.43 ± 1.43 | <.0001* | 0.52 (0.41, 0.67) |
Tuberculosis | 14 (9.5%) | 6 (4.0%) | 0.0633 | 2.54 (0.95, 6.81) |
Died | 16 (11.4%) | 18 (12.5%) | 0.7641 | 0.90 (0.44, 1.84) |